Last Updated:
Name Designation Appointment Date Status
Nimesh Manharlal Dixit

Appointed as Director since May 2013

 Director 24-May-2013 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Ballingamma Pharma Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Ravikumar Venkatramuloo Bogam

Appointed as Director since April 2013

 Director 30-Apr-2013 Current
Nagendra Kshamanath Yadav

Appointed as Director since April 2013

 Director 30-Apr-2013 Current

People Timeline

Explore the timeline of key personnel in Ballingamma Pharma Private Limited's leadership journey.

Contact Details
  • Address B-701,Akruli Pushkar Chs Ltd, Rdp-1,Akr-4 Akruli Rd, Kandivali (E), Nr Lokhandwala, Complex, Mumbai Maharashtra, 400101, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400101
  • Country India
  • Website -
Frequently Asked Questions
You can contact Ballingamma Pharma Private Limited through their registered address at B-701,Akruli Pushkar Chs Ltd, Rdp-1,Akr-4 Akruli Rd, Kandivali (E), Nr Lokhandwala, Complex, Mumbai Maharashtra, 400101, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Ballingamma Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • NIMESH MANHARLAL DIXIT
  • RAVIKUMAR VENKATRAMULOO BOGAM
  • NAGENDRA KSHAMANATH YADAV
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available